Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (EGX: RMDA)

EGX: RMDA Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 28, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	5,578	2,459	2,892	2,400	2,928	3,543
Market Cap Growth	119.22%	-14.96%	20.51%	-18.04%	-17.35%	-
Enterprise Value	6,437	3,259	3,284	3,006	3,403	4,127
Last Close Price	3.71	1.60	1.90	1.52	1.86	2.25
PE Ratio	20.95	11.00	12.63	14.42	30.04	43.00
Forward PE	12.05	7.72	9.25	10.10	13.64	-
PS Ratio	2.39	1.28	1.95	1.93	3.05	3.96
PB Ratio	2.96	1.39	1.90	1.78	2.47	3.31
P/TBV Ratio	3.54	2.10	2.73	2.50	3.02	3.66
P/FCF Ratio	614.81	-	-	12.72	-	-
P/OCF Ratio	71.23	-	98.55	9.94	-	66.60
PEG Ratio	0.28	0.28	0.28	0.27	0.30	-
EV/Sales Ratio	2.78	1.70	2.21	2.41	3.54	4.62
EV/EBITDA Ratio	10.35	6.33	8.14	9.49	14.21	16.23
EV/EBIT Ratio	11.83	7.31	9.60	10.96	18.20	18.93
EV/FCF Ratio	709.56	-	-	15.93	-	-
Debt / Equity Ratio	0.60	0.63	0.61	0.65	0.79	0.59
Debt / EBITDA Ratio	1.85	2.15	2.28	2.75	3.82	2.47
Debt / FCF Ratio	126.51	-	-	4.66	-	-
Asset Turnover	0.68	0.64	0.57	0.53	0.47	0.58
Inventory Turnover	2.91	3.13	2.52	2.37	1.98	1.99
Quick Ratio	0.57	0.54	0.62	0.76	0.76	1.14
Current Ratio	1.52	1.47	1.49	1.44	1.51	1.81
Return on Equity (ROE)	16.57%	15.35%	17.63%	14.24%	9.89%	10.58%
Return on Assets (ROA)	9.92%	9.30%	8.24%	7.34%	5.68%	8.82%
Return on Capital (ROIC)	11.49%	10.43%	9.14%	7.90%	6.13%	9.87%
Earnings Yield	4.77%	9.96%	8.49%	7.55%	3.83%	2.33%
FCF Yield	0.16%	-5.51%	-0.17%	7.86%	-8.51%	-0.80%
Dividend Yield	1.81%	4.19%	-	-	-	-
Payout Ratio	17.84%	6.85%	9.89%	8.12%	-	-
Buyback Yield / Dilution	-0.76%	-1.27%	2.62%	-	-0.00%	-17.52%
Total Shareholder Return	1.05%	2.91%	2.62%	-	-0.00%	-17.52%

Source: S&P Capital IQ. Standard template. Financial Sources.